02/12/2025
🔬 New Evidence: Vitamin D Strengthens Anti-Cancer Therapy in Oral Squamous Cell Carcinoma
Strong cancer medications can cause challenging side effects, but a new study shows that adding calcitriol (active vitamin D) may enhance the effectiveness of buparlisib, even when the dose is reduced. This could mark an important step toward developing safer and more targeted treatment options for individuals with oral squamous cell carcinoma.
What the results could mean for patients:
▫️ Calcitriol may allow doctors to use reduced doses of buparlisib while keeping its anticancer effect strong.
▫️ Lower treatment intensity could help reduce side effects and improve comfort during therapy.
▫️ If confirmed in further studies, this combination may become a future option in oral cancer care.
🔗 Read more: https://dmp.umw.edu.pl/en/article/2025/62/5/891/